ribavirin has been researched along with Acute Idiopathic Facial Neuropathy in 5 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (80.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barut, S; Basak, AN; Eken, AG; Karaer, H; Oksuz, E | 1 |
| Fakharzadeh, E; Jabbari, H; Merat, S; Sharifi, AH; Zamini, H | 1 |
| Calvit, TB; Cash, BD; Holtzmuller, KC; Hwang, I | 1 |
| Alexander, GJ; Hoare, M; Woodall, T | 1 |
| Cho, H; Kim, YM; Lee, JS; Lee, MY | 1 |
5 other study(ies) available for ribavirin and Acute Idiopathic Facial Neuropathy
| Article | Year |
|---|---|
Bell's palsy and choreiform movements during peginterferon alpha and ribavirin therapy.
Topics: Antiviral Agents; Bell Palsy; Chorea; Female; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2009 |
Bell's palsy associated with chronic HCV infection before and during peginterferon alfa and ribavirin therapy.
Topics: Adult; Antiviral Agents; Bell Palsy; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin | 2011 |
Bell's palsy: a rare complication of interferon therapy for hepatitis C.
Topics: Adult; Bell Palsy; Dose-Response Relationship, Drug; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Hepatitis C; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Recombinant Proteins; Ribavirin; Risk Assessment; Severity of Illness Index | 2004 |
Bell's palsy associated with IFN-alpha and ribavirin therapy for hepatitis C virus infection.
Topics: Adult; Antiviral Agents; Bell Palsy; Hepatitis C, Chronic; Humans; Interferon Type I; Male; Middle Aged; Myelin Sheath; Recombinant Proteins; Ribavirin; Schwann Cells; Self Tolerance; Substance Abuse, Intravenous | 2005 |
[A case of Bell's palsy associated with peginterferon Alfa-2a and ribavirin therapy for chronic hepatitis C virus infection].
Topics: Adult; Antiviral Agents; Bell Palsy; Hepatitis C, Chronic; Humans; Interferon alpha-2; Interferon-alpha; Male; Middle Aged; Polyethylene Glycols; Recombinant Proteins; Ribavirin; Treatment Outcome | 2006 |